Walgreens Sees "Optionality," Or Flexible Participation, As The Way Forward With Hybrid Trials

Walgreens Head of Decentralized Clinical Trials John Campbell believes clinical trials will one day allow patient to choose when and where they will participate in a clinical trial. Campbell contends true patient centricity would allow patients to pick whether they’re seen at home, at a site, at a pharmacy, or any combination of locations.